1. Irvine DA, Copland M. Targeting hedgehog in hematologic malignancy. Blood. 2012;119(10):2196–204.
2. Pfizer. US FDA approves DAURISMO™ (glasdegib) for adult patients with newly-diagnosed acute myeloid leukemia (AML) for whom intensive chemotherapy is not an option. 2018.
http://www.pfizer.com/
. Accessed 23 Nov 2018.
3. Pfizer. DaurismoTM (glasdegib) tablets, for oral use: US prescribing information. 2018.
http://www.fda.gov/
. Accessed 26 Nov 2018.
4. US FDA. FDA approves new treatment for patients with acute myeloid leukemia. 2018.
http://www.fda.gov/
. Accessed 23 Nov 2018.
5. US FDA. Orphan drug designations and approvals. 2017.
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/listResult.cfm
. Accessed 20 Dec 2018.